Timeliness of infant vaccination and factors related with delay in Flanders, Belgium
Highlights • One third of infants in Flanders receive MMR1 vaccine delayed according to the recommended schedule. • Although 38% of infants receive DTP1 vaccine in time, 92% of DTP3 doses are administered with delay. • An improvement in timely vaccination was achieved over the last decade. • Determi...
Gespeichert in:
| Veröffentlicht in: | Vaccine 2014-01, Vol.32 (2), p.284-289 |
|---|---|
| Hauptverfasser: | , , , , , , |
| Format: | Artikel |
| Sprache: | eng |
| Schlagworte: | |
| Online-Zugang: | Volltext |
| Tags: |
Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
|
| container_end_page | 289 |
|---|---|
| container_issue | 2 |
| container_start_page | 284 |
| container_title | Vaccine |
| container_volume | 32 |
| creator | Lernout, Tinne Theeten, Heidi Hens, Niel Braeckman, Tessa Roelants, Mathieu Hoppenbrouwers, Karel Van Damme, Pierre |
| description | Highlights • One third of infants in Flanders receive MMR1 vaccine delayed according to the recommended schedule. • Although 38% of infants receive DTP1 vaccine in time, 92% of DTP3 doses are administered with delay. • An improvement in timely vaccination was achieved over the last decade. • Determining factors for remaining delay are the main vaccinator, mother's origin, ranking of the child and income. |
| doi_str_mv | 10.1016/j.vaccine.2013.10.084 |
| format | Article |
| fullrecord | <record><control><sourceid>proquest_cross</sourceid><recordid>TN_cdi_proquest_miscellaneous_1516753928</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><els_id>S0264410X13014916</els_id><sourcerecordid>3395119641</sourcerecordid><originalsourceid>FETCH-LOGICAL-c511t-f76444fd30f1ec32e82c6b90b8b2314a7bc074c945b11e64b15cc6e8dcc1e1a63</originalsourceid><addsrcrecordid>eNqFkk1v1DAQhiMEokvhJ4AsISQOZPH4K84F1FYUkCpxYJG4Wc5kAl6ySbGTov33ONqFSr30ZM3omdcz805RPAe-Bg7m7XZ94xHDQGvBQebcmlv1oFiBrWQpNNiHxYoLo0oF_PtJ8SSlLedcS6gfFydCCS1MbVfFZhN21GeZlNjYsTB0fpjYQdpPYRyYH1rWeZzGmFik3k_Usj9h-snaHOxzBbvsM0MxvWHn1P8I8-5p8ajzfaJnx_e0-Hb5YXPxqbz68vHzxdlViRpgKrvKKKW6VvIOCKUgK9A0NW9sIyQoXzXIK4W10g0AGdWARjRkW0Qg8EaeFq8Putdx_D1TmtwuJKQ-90PjnBxoMJWWtbD3o6rmlZVKiIy-vINuxzkOeZAsqKECw02dKX2gMI4pRercdQw7H_cOuFscclt3dMgtDi3p7FCue3FUn5sdtf-r_lmSgVdHwCf0fRf9gCHdcjZTuuKZe3_gKG_4JlB0CQMNSG2IhJNrx3BvK-_uKGC-hJA__UV7SrdTuyQcd1-Xc1quCSTP6wIj_wI0a8TT</addsrcrecordid><sourcetype>Aggregation Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>1551716069</pqid></control><display><type>article</type><title>Timeliness of infant vaccination and factors related with delay in Flanders, Belgium</title><source>MEDLINE</source><source>Elsevier ScienceDirect Journals</source><creator>Lernout, Tinne ; Theeten, Heidi ; Hens, Niel ; Braeckman, Tessa ; Roelants, Mathieu ; Hoppenbrouwers, Karel ; Van Damme, Pierre</creator><creatorcontrib>Lernout, Tinne ; Theeten, Heidi ; Hens, Niel ; Braeckman, Tessa ; Roelants, Mathieu ; Hoppenbrouwers, Karel ; Van Damme, Pierre</creatorcontrib><description>Highlights • One third of infants in Flanders receive MMR1 vaccine delayed according to the recommended schedule. • Although 38% of infants receive DTP1 vaccine in time, 92% of DTP3 doses are administered with delay. • An improvement in timely vaccination was achieved over the last decade. • Determining factors for remaining delay are the main vaccinator, mother's origin, ranking of the child and income.</description><identifier>ISSN: 0264-410X</identifier><identifier>EISSN: 1873-2518</identifier><identifier>DOI: 10.1016/j.vaccine.2013.10.084</identifier><identifier>PMID: 24252698</identifier><identifier>CODEN: VACCDE</identifier><language>eng</language><publisher>Kidlington: Elsevier Ltd</publisher><subject>Age ; Allergy and Immunology ; Applied microbiology ; Belgium ; Biological and medical sciences ; Clinics ; Confidence intervals ; Cross-Sectional Studies ; Diphtheria-Tetanus-Pertussis Vaccine - administration & dosage ; Families & family life ; Family income ; Family physicians ; Flanders ; Fundamental and applied biological sciences. Psychology ; Humans ; Immunization Schedule ; Infant ; Infant vaccination ; Infants ; Infectious diseases ; Measles ; Measles-Mumps-Rubella Vaccine - administration & dosage ; Medical research ; Microbiology ; Patient Compliance - statistics & numerical data ; Population Surveillance ; Public health ; Regression analysis ; Risk Factors ; Studies ; Survival analysis ; Time Factors ; Timeliness ; Vaccination - trends ; Vaccines ; Vaccines, antisera, therapeutical immunoglobulins and monoclonal antibodies (general aspects) ; Whooping cough</subject><ispartof>Vaccine, 2014-01, Vol.32 (2), p.284-289</ispartof><rights>Elsevier Ltd</rights><rights>2013 Elsevier Ltd</rights><rights>2015 INIST-CNRS</rights><rights>Copyright © 2013 Elsevier Ltd. All rights reserved.</rights><rights>Copyright Elsevier Limited Jan 3, 2014</rights><lds50>peer_reviewed</lds50><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c511t-f76444fd30f1ec32e82c6b90b8b2314a7bc074c945b11e64b15cc6e8dcc1e1a63</citedby><cites>FETCH-LOGICAL-c511t-f76444fd30f1ec32e82c6b90b8b2314a7bc074c945b11e64b15cc6e8dcc1e1a63</cites><orcidid>0000-0002-3749-0475</orcidid></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktohtml>$$Uhttps://www.sciencedirect.com/science/article/pii/S0264410X13014916$$EHTML$$P50$$Gelsevier$$H</linktohtml><link.rule.ids>314,776,780,3537,27901,27902,65306</link.rule.ids><backlink>$$Uhttp://pascal-francis.inist.fr/vibad/index.php?action=getRecordDetail&idt=28269570$$DView record in Pascal Francis$$Hfree_for_read</backlink><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/24252698$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Lernout, Tinne</creatorcontrib><creatorcontrib>Theeten, Heidi</creatorcontrib><creatorcontrib>Hens, Niel</creatorcontrib><creatorcontrib>Braeckman, Tessa</creatorcontrib><creatorcontrib>Roelants, Mathieu</creatorcontrib><creatorcontrib>Hoppenbrouwers, Karel</creatorcontrib><creatorcontrib>Van Damme, Pierre</creatorcontrib><title>Timeliness of infant vaccination and factors related with delay in Flanders, Belgium</title><title>Vaccine</title><addtitle>Vaccine</addtitle><description>Highlights • One third of infants in Flanders receive MMR1 vaccine delayed according to the recommended schedule. • Although 38% of infants receive DTP1 vaccine in time, 92% of DTP3 doses are administered with delay. • An improvement in timely vaccination was achieved over the last decade. • Determining factors for remaining delay are the main vaccinator, mother's origin, ranking of the child and income.</description><subject>Age</subject><subject>Allergy and Immunology</subject><subject>Applied microbiology</subject><subject>Belgium</subject><subject>Biological and medical sciences</subject><subject>Clinics</subject><subject>Confidence intervals</subject><subject>Cross-Sectional Studies</subject><subject>Diphtheria-Tetanus-Pertussis Vaccine - administration & dosage</subject><subject>Families & family life</subject><subject>Family income</subject><subject>Family physicians</subject><subject>Flanders</subject><subject>Fundamental and applied biological sciences. Psychology</subject><subject>Humans</subject><subject>Immunization Schedule</subject><subject>Infant</subject><subject>Infant vaccination</subject><subject>Infants</subject><subject>Infectious diseases</subject><subject>Measles</subject><subject>Measles-Mumps-Rubella Vaccine - administration & dosage</subject><subject>Medical research</subject><subject>Microbiology</subject><subject>Patient Compliance - statistics & numerical data</subject><subject>Population Surveillance</subject><subject>Public health</subject><subject>Regression analysis</subject><subject>Risk Factors</subject><subject>Studies</subject><subject>Survival analysis</subject><subject>Time Factors</subject><subject>Timeliness</subject><subject>Vaccination - trends</subject><subject>Vaccines</subject><subject>Vaccines, antisera, therapeutical immunoglobulins and monoclonal antibodies (general aspects)</subject><subject>Whooping cough</subject><issn>0264-410X</issn><issn>1873-2518</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2014</creationdate><recordtype>article</recordtype><sourceid>EIF</sourceid><sourceid>8G5</sourceid><sourceid>BENPR</sourceid><sourceid>GUQSH</sourceid><sourceid>M2O</sourceid><recordid>eNqFkk1v1DAQhiMEokvhJ4AsISQOZPH4K84F1FYUkCpxYJG4Wc5kAl6ySbGTov33ONqFSr30ZM3omdcz805RPAe-Bg7m7XZ94xHDQGvBQebcmlv1oFiBrWQpNNiHxYoLo0oF_PtJ8SSlLedcS6gfFydCCS1MbVfFZhN21GeZlNjYsTB0fpjYQdpPYRyYH1rWeZzGmFik3k_Usj9h-snaHOxzBbvsM0MxvWHn1P8I8-5p8ajzfaJnx_e0-Hb5YXPxqbz68vHzxdlViRpgKrvKKKW6VvIOCKUgK9A0NW9sIyQoXzXIK4W10g0AGdWARjRkW0Qg8EaeFq8Putdx_D1TmtwuJKQ-90PjnBxoMJWWtbD3o6rmlZVKiIy-vINuxzkOeZAsqKECw02dKX2gMI4pRercdQw7H_cOuFscclt3dMgtDi3p7FCue3FUn5sdtf-r_lmSgVdHwCf0fRf9gCHdcjZTuuKZe3_gKG_4JlB0CQMNSG2IhJNrx3BvK-_uKGC-hJA__UV7SrdTuyQcd1-Xc1quCSTP6wIj_wI0a8TT</recordid><startdate>20140103</startdate><enddate>20140103</enddate><creator>Lernout, Tinne</creator><creator>Theeten, Heidi</creator><creator>Hens, Niel</creator><creator>Braeckman, Tessa</creator><creator>Roelants, Mathieu</creator><creator>Hoppenbrouwers, Karel</creator><creator>Van Damme, Pierre</creator><general>Elsevier Ltd</general><general>Elsevier</general><general>Elsevier Limited</general><scope>IQODW</scope><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>3V.</scope><scope>7QL</scope><scope>7RV</scope><scope>7T2</scope><scope>7T5</scope><scope>7U9</scope><scope>7X7</scope><scope>7XB</scope><scope>88C</scope><scope>88E</scope><scope>8AO</scope><scope>8C1</scope><scope>8FE</scope><scope>8FH</scope><scope>8FI</scope><scope>8FJ</scope><scope>8FK</scope><scope>8G5</scope><scope>ABUWG</scope><scope>AEUYN</scope><scope>AFKRA</scope><scope>AZQEC</scope><scope>BBNVY</scope><scope>BENPR</scope><scope>BHPHI</scope><scope>C1K</scope><scope>CCPQU</scope><scope>DWQXO</scope><scope>FYUFA</scope><scope>GHDGH</scope><scope>GNUQQ</scope><scope>GUQSH</scope><scope>H94</scope><scope>HCIFZ</scope><scope>K9-</scope><scope>K9.</scope><scope>KB0</scope><scope>LK8</scope><scope>M0R</scope><scope>M0S</scope><scope>M0T</scope><scope>M1P</scope><scope>M2O</scope><scope>M7N</scope><scope>M7P</scope><scope>MBDVC</scope><scope>NAPCQ</scope><scope>PQEST</scope><scope>PQQKQ</scope><scope>PQUKI</scope><scope>Q9U</scope><scope>7X8</scope><orcidid>https://orcid.org/0000-0002-3749-0475</orcidid></search><sort><creationdate>20140103</creationdate><title>Timeliness of infant vaccination and factors related with delay in Flanders, Belgium</title><author>Lernout, Tinne ; Theeten, Heidi ; Hens, Niel ; Braeckman, Tessa ; Roelants, Mathieu ; Hoppenbrouwers, Karel ; Van Damme, Pierre</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c511t-f76444fd30f1ec32e82c6b90b8b2314a7bc074c945b11e64b15cc6e8dcc1e1a63</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2014</creationdate><topic>Age</topic><topic>Allergy and Immunology</topic><topic>Applied microbiology</topic><topic>Belgium</topic><topic>Biological and medical sciences</topic><topic>Clinics</topic><topic>Confidence intervals</topic><topic>Cross-Sectional Studies</topic><topic>Diphtheria-Tetanus-Pertussis Vaccine - administration & dosage</topic><topic>Families & family life</topic><topic>Family income</topic><topic>Family physicians</topic><topic>Flanders</topic><topic>Fundamental and applied biological sciences. Psychology</topic><topic>Humans</topic><topic>Immunization Schedule</topic><topic>Infant</topic><topic>Infant vaccination</topic><topic>Infants</topic><topic>Infectious diseases</topic><topic>Measles</topic><topic>Measles-Mumps-Rubella Vaccine - administration & dosage</topic><topic>Medical research</topic><topic>Microbiology</topic><topic>Patient Compliance - statistics & numerical data</topic><topic>Population Surveillance</topic><topic>Public health</topic><topic>Regression analysis</topic><topic>Risk Factors</topic><topic>Studies</topic><topic>Survival analysis</topic><topic>Time Factors</topic><topic>Timeliness</topic><topic>Vaccination - trends</topic><topic>Vaccines</topic><topic>Vaccines, antisera, therapeutical immunoglobulins and monoclonal antibodies (general aspects)</topic><topic>Whooping cough</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Lernout, Tinne</creatorcontrib><creatorcontrib>Theeten, Heidi</creatorcontrib><creatorcontrib>Hens, Niel</creatorcontrib><creatorcontrib>Braeckman, Tessa</creatorcontrib><creatorcontrib>Roelants, Mathieu</creatorcontrib><creatorcontrib>Hoppenbrouwers, Karel</creatorcontrib><creatorcontrib>Van Damme, Pierre</creatorcontrib><collection>Pascal-Francis</collection><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>CrossRef</collection><collection>ProQuest Central (Corporate)</collection><collection>Bacteriology Abstracts (Microbiology B)</collection><collection>Nursing & Allied Health Database</collection><collection>Health and Safety Science Abstracts (Full archive)</collection><collection>Immunology Abstracts</collection><collection>Virology and AIDS Abstracts</collection><collection>Health & Medical Collection</collection><collection>ProQuest Central (purchase pre-March 2016)</collection><collection>Healthcare Administration Database (Alumni)</collection><collection>Medical Database (Alumni Edition)</collection><collection>ProQuest Pharma Collection</collection><collection>Public Health Database</collection><collection>ProQuest SciTech Collection</collection><collection>ProQuest Natural Science Collection</collection><collection>Hospital Premium Collection</collection><collection>Hospital Premium Collection (Alumni Edition)</collection><collection>ProQuest Central (Alumni) (purchase pre-March 2016)</collection><collection>Research Library (Alumni Edition)</collection><collection>ProQuest Central (Alumni Edition)</collection><collection>ProQuest One Sustainability</collection><collection>ProQuest Central UK/Ireland</collection><collection>ProQuest Central Essentials</collection><collection>Biological Science Collection</collection><collection>ProQuest Central</collection><collection>Natural Science Collection</collection><collection>Environmental Sciences and Pollution Management</collection><collection>ProQuest One Community College</collection><collection>ProQuest Central Korea</collection><collection>Health Research Premium Collection</collection><collection>Health Research Premium Collection (Alumni)</collection><collection>ProQuest Central Student</collection><collection>Research Library Prep</collection><collection>AIDS and Cancer Research Abstracts</collection><collection>SciTech Premium Collection</collection><collection>Consumer Health Database (Alumni Edition)</collection><collection>ProQuest Health & Medical Complete (Alumni)</collection><collection>Nursing & Allied Health Database (Alumni Edition)</collection><collection>ProQuest Biological Science Collection</collection><collection>Consumer Health Database</collection><collection>Health & Medical Collection (Alumni Edition)</collection><collection>Healthcare Administration Database</collection><collection>Medical Database</collection><collection>Research Library</collection><collection>Algology Mycology and Protozoology Abstracts (Microbiology C)</collection><collection>Biological Science Database</collection><collection>Research Library (Corporate)</collection><collection>Nursing & Allied Health Premium</collection><collection>ProQuest One Academic Eastern Edition (DO NOT USE)</collection><collection>ProQuest One Academic</collection><collection>ProQuest One Academic UKI Edition</collection><collection>ProQuest Central Basic</collection><collection>MEDLINE - Academic</collection><jtitle>Vaccine</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Lernout, Tinne</au><au>Theeten, Heidi</au><au>Hens, Niel</au><au>Braeckman, Tessa</au><au>Roelants, Mathieu</au><au>Hoppenbrouwers, Karel</au><au>Van Damme, Pierre</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Timeliness of infant vaccination and factors related with delay in Flanders, Belgium</atitle><jtitle>Vaccine</jtitle><addtitle>Vaccine</addtitle><date>2014-01-03</date><risdate>2014</risdate><volume>32</volume><issue>2</issue><spage>284</spage><epage>289</epage><pages>284-289</pages><issn>0264-410X</issn><eissn>1873-2518</eissn><coden>VACCDE</coden><abstract>Highlights • One third of infants in Flanders receive MMR1 vaccine delayed according to the recommended schedule. • Although 38% of infants receive DTP1 vaccine in time, 92% of DTP3 doses are administered with delay. • An improvement in timely vaccination was achieved over the last decade. • Determining factors for remaining delay are the main vaccinator, mother's origin, ranking of the child and income.</abstract><cop>Kidlington</cop><pub>Elsevier Ltd</pub><pmid>24252698</pmid><doi>10.1016/j.vaccine.2013.10.084</doi><tpages>6</tpages><orcidid>https://orcid.org/0000-0002-3749-0475</orcidid></addata></record> |
| fulltext | fulltext |
| identifier | ISSN: 0264-410X |
| ispartof | Vaccine, 2014-01, Vol.32 (2), p.284-289 |
| issn | 0264-410X 1873-2518 |
| language | eng |
| recordid | cdi_proquest_miscellaneous_1516753928 |
| source | MEDLINE; Elsevier ScienceDirect Journals |
| subjects | Age Allergy and Immunology Applied microbiology Belgium Biological and medical sciences Clinics Confidence intervals Cross-Sectional Studies Diphtheria-Tetanus-Pertussis Vaccine - administration & dosage Families & family life Family income Family physicians Flanders Fundamental and applied biological sciences. Psychology Humans Immunization Schedule Infant Infant vaccination Infants Infectious diseases Measles Measles-Mumps-Rubella Vaccine - administration & dosage Medical research Microbiology Patient Compliance - statistics & numerical data Population Surveillance Public health Regression analysis Risk Factors Studies Survival analysis Time Factors Timeliness Vaccination - trends Vaccines Vaccines, antisera, therapeutical immunoglobulins and monoclonal antibodies (general aspects) Whooping cough |
| title | Timeliness of infant vaccination and factors related with delay in Flanders, Belgium |
| url | https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-02-02T07%3A12%3A04IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_cross&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Timeliness%20of%20infant%20vaccination%20and%20factors%20related%20with%20delay%20in%20Flanders,%20Belgium&rft.jtitle=Vaccine&rft.au=Lernout,%20Tinne&rft.date=2014-01-03&rft.volume=32&rft.issue=2&rft.spage=284&rft.epage=289&rft.pages=284-289&rft.issn=0264-410X&rft.eissn=1873-2518&rft.coden=VACCDE&rft_id=info:doi/10.1016/j.vaccine.2013.10.084&rft_dat=%3Cproquest_cross%3E3395119641%3C/proquest_cross%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_pqid=1551716069&rft_id=info:pmid/24252698&rft_els_id=S0264410X13014916&rfr_iscdi=true |